Lennox International Inc
SWB:LXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lennox International Inc
SWB:LXI
|
US |
|
Siam Makro PCL
OTC:SMKUY
|
TH |
|
C
|
CVS Health Corp
DUS:CVS
|
US |
|
Clicks Group Ltd
F:N1C
|
ZA |
|
F
|
Franklin Electric Co Inc
XBER:FE4
|
US |
|
D
|
Dechra Pharmaceuticals PLC
SWB:1PK
|
UK |
|
Indaptus Therapeutics Inc
NASDAQ:INDP
|
US |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
Medallion Financial Corp
NASDAQ:MFIN
|
US |
|
S
|
State Street Corp
SWB:ZYA
|
US |
Wall St Price Targets
LXI Price Targets Summary
Lennox International Inc
According to Wall Street analysts, the average 1-year price target for LXI is 474.31 EUR with a low forecast of 381.59 EUR and a high forecast of 568.6 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LXI's stock price target?
Price Target
474.31
EUR
According to Wall Street analysts, the average 1-year price target for LXI is 474.31 EUR with a low forecast of 381.59 EUR and a high forecast of 568.6 EUR.
What is the Revenue forecast for Lennox International Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Lennox International Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 5 years is 10%.
What is the Net Income forecast for Lennox International Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 5 years is 12%.
